In:
International Journal of Cancer, Wiley, Vol. 146, No. 6 ( 2020-03-15), p. 1503-1513
Abstract:
What's new? Low‐dose computed tomography (LDCT) is an emerging tool for early lung cancer detection. Here, as part of the German Lung Cancer Screening Intervention trial, the benefits of annual LDCT screening were examined in long‐term smokers ages 50 to 69. In men and women combined, no statistically significant reduction in lung cancer mortality was observed after five annual rounds of LDCT screening compared to controls. Separate analyses by sex, however, revealed significant reductions in lung cancer mortality among the women who underwent LDCT. The findings support the systematic use of LDCT in lung cancer screening, though critical optimization strategies await investigation.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
